The panel comprised of two immortalized HMEC cell lines, fifteen tumorigenic breast cancer cell lines (representing all three molecular subtypes), and one teratocarcinoma cell line known to produce HML-2 transcripts and retroviral-like particles (RVLPs) at high levels [9, 36]. The gene discussed is CLEC10A; the disease is breast cancer.